{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:14Z","timestamp":1783138634969,"version":"3.54.6"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.2169\/internalmedicine.6343-25","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:07:10Z","timestamp":1762985230000},"page":"1815-1820","source":"Crossref","is-referenced-by-count":0,"title":["Contrasting Outcomes in Two Cases of Anti-contactin-associated Protein-like 2 Autoimmune Encephalitis"],"prefix":"10.2169","volume":"65","author":[{"given":"Kazuki","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Neurology, Hakodate Municipal Hospital, Japan"},{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hakodate Municipal Hospital, Japan"},{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hakodate Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Tasaki","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K<sup>+<\/sup> channels of peripheral nerves. Ann Neurol 38: 714-722, 1995.","DOI":"10.1002\/ana.410380505"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K<sup>+<\/sup> channels are implicated in neuromyotonia. Ann Neurol 41: 238-246, 1997.","DOI":"10.1002\/ana.410410215"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan&apos;s syndrome and acquired neuromyotonia. Brain 133: 2734-2748, 2010.","DOI":"10.1093\/brain\/awq213"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hivert B, Pinatel D, Labasque M, Tricaud N, Goutebroze L, Faivre-Sarrailh C. Assembly of juxtaparanodes in myelinating DRG culture: differential clustering of the Kv1\/Caspr2 complex and scaffolding protein 4.1B. Glia 64: 840-852, 2016.","DOI":"10.1002\/glia.22968"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J. Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci 48: 1906-1923, 2018.","DOI":"10.1111\/ejn.14081"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Patterson KR, Dalmau J, Lancaster E. Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia. Ann Neurol 83: 40-51, 2018.","DOI":"10.1002\/ana.25120"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bien CG, Mirzadjanova Z, Baumgartner C, et al. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Eur J Neurol 24: 175-186, 2017.","DOI":"10.1111\/ene.13180"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Joubert B, Saint-Martin M, Noraz N, et al. Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol 73: 1115-1124, 2016.","DOI":"10.1001\/jamaneurol.2016.1585"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267: 1137-1146, 2020.","DOI":"10.1007\/s00415-019-09686-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pinatel D, Hivert B, Boucraut J, et al. Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis. Front Cell Neurosci 9: 265, 2015.","DOI":"10.3389\/fncel.2015.00265"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E. Caspr2 autoantibodies target multiple epitopes. Neurol Neuroimmunol Neuroinflamm 2: e127, 2015.","DOI":"10.1212\/NXI.0000000000000127"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol 21: 412-423, 2021.","DOI":"10.1136\/practneurol-2020-002567"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Qin X, Yang H, Zhu F, Wang Q, Shan W. Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study. Front Immunol 12: 652864, 2021.","DOI":"10.3389\/fimmu.2021.652864"},{"key":"14","unstructured":"14. Thaler FS, Zimmermann L, Kammermeier S, et al. Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry. Neurol Neuroimmunol Neuroinflamm 8: e1088, 2021."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69: 892-900, 2011.","DOI":"10.1002\/ana.22307"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72: 241-255, 2012.","DOI":"10.1002\/ana.23577"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Titulaer MJ, H\u00f6ftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75: 411-428, 2014.","DOI":"10.1002\/ana.24117"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Liu P, Bai M, Yan X, et al. Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report. Ther Adv Neurol Disord 13: 1756286420969462, 2020.","DOI":"10.1177\/1756286420969462"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Viti V, Cutillo G, Rubin M, Zanetta C, Rocca MA, Filippi M. Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report. J Neurol 272: 342, 2025.","DOI":"10.1007\/s00415-025-13096-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sinmaz N, Nguyen T, Tea F, Dale RC, Brilot F. Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. J Neuroinflammation 13: 219, 2016.","DOI":"10.1186\/s12974-016-0678-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tzartos JS, Karagiorgou K, Tzanetakos D, et al. Deciphering anti-MOG IgG antibodies: clinical and radiological spectrum, and comparison of antibody detection assays. J Neurol Sci 410: 116673, 2020.","DOI":"10.1016\/j.jns.2020.116673"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6343-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:31:21Z","timestamp":1783135881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6343-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":21,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6343-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"6343-25"}}